about
Investigating the feasibility and acceptability of a cognitive behavioural suicide prevention therapy for people in acute psychiatric wards (the 'INSITE' trial): study protocol for a randomised controlled trialThe moderating effects of coping and self-esteem on the relationship between defeat, entrapment and suicidality in a sample of prisoners at high risk of suicide.Cognitive-behavioural suicide prevention for male prisoners: a pilot randomized controlled trial.Staff experiences and perceptions of working with in-patients who are suicidal: qualitative analysisClinical management following self-harm in a UK-wide primary care cohort.Cognitive Behavioural Suicide Prevention for Male Prisoners: Case examplesA systematic review of service-user reasons for adherence and nonadherence to neuroleptic medication in psychosis.Premature Death Among Primary Care Patients With a History of Self-Harm.Understanding Outcomes in a Randomized Controlled Trial of a Ward-based Intervention on Psychiatric Inpatient Wards: A Qualitative Analysis of Staff and Patient Experiences.The exacerbating influence of hopelessness on other known risk factors for repeat self-harm and suicide.Effect of hopelessness on the links between psychiatric symptoms and suicidality in a vulnerable population at risk of suicide.A qualitative study: experiences of stigma by people with mental health problems.Personal Accounts of Discontinuing Neuroleptic Medication for Psychosis.A qualitative analysis of suicidal psychiatric inpatients views and expectations of psychological therapy to counter suicidal thoughts, acts and deathsFeasibility and acceptability of suicide prevention therapy on acute psychiatric wards: randomised controlled trialQualitative analysis of ward staff experiences during research of a novel suicide-prevention psychological therapy for psychiatric inpatients: Understanding the barriers and facilitators
P50
Q27334611-68754641-581B-41BA-BDF2-8CB5F88A47BEQ36379665-033D8203-3BF7-421E-ACB5-5A329C8F7C83Q36379669-6904DEC4-463A-4537-A996-5CC93D1B40BFQ36412887-655732A7-BA34-43B1-80BE-FE041CA3C553Q36909980-74CE269D-1D7D-47A9-A289-4D4EEDAD530CQ37305401-FBF74115-F919-4075-85E7-3C51BEA0B686Q38795911-10151149-44EC-4721-9D32-C638838EA9C8Q38797039-377615D4-6435-47E5-8645-60FF7D68F09BQ39062509-1E0E2ABD-AA4E-475D-8970-1261E1225EEAQ41128996-BE536849-9C29-4F6C-A38D-FD9802F82DF5Q47323781-29B756DC-493C-4312-9847-1D287C86A73BQ47554624-1B2F84DE-23D3-4FCC-92C0-2780CB715482Q50527605-33397947-2410-402C-BBD7-1ACC2D17B977Q57456036-648B331C-C64A-44B0-BFCE-59636A591B5FQ64259155-E0117E0D-C7B4-40D9-B589-0190C8B9E9ADQ90255440-C42DC5A7-4AAF-495B-9E82-75A2A7AC1D70
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Yvonne Awenat
@en
Yvonne Awenat
@nl
type
label
Yvonne Awenat
@en
Yvonne Awenat
@nl
prefLabel
Yvonne Awenat
@en
Yvonne Awenat
@nl
P31
P496
0000-0002-0767-4994